Dyfyniad APA

Muller, J., Bolomsky, A., Dubois, S., Duray, E., Stangelberger, K., Plougonven, E., . . . Caers, J. (2018). Maternal embryonic leucine zipper kinase inhibitor OTSSP167 has preclinical activity in multiple myeloma bone disease. Haematologica.

Dyfyniad Arddull Chicago

Muller, Joséphine, et al. "Maternal Embryonic Leucine Zipper Kinase Inhibitor OTSSP167 Has Preclinical Activity in Multiple Myeloma Bone Disease." Haematologica 2018.

Dyfyniad MLA

Muller, Joséphine, et al. "Maternal Embryonic Leucine Zipper Kinase Inhibitor OTSSP167 Has Preclinical Activity in Multiple Myeloma Bone Disease." Haematologica 2018.

Rhybudd: Mae'n bosib nad yw'r dyfyniadau hyn bob amser yn 100% cywir.